Capital Performance Advisors LLP Pulse Biosciences, Inc. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 4 shares of PLSE stock, worth $58. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4Holding current value
$58% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLSE
# of Institutions
66Shares Held
4.8MCall Options Held
138KPut Options Held
96.2K-
Black Rock Inc. New York, NY1.15MShares$16.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA905KShares$13.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC783KShares$11.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA424KShares$6.17 Million0.0% of portfolio
-
State Street Corp Boston, MA392KShares$5.7 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $541M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...